Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7090843 | NA | Recombinant anti-CD30 antibodies and uses thereof |
Aug, 2023
(8 months ago) | |
US7829531 | NA | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
Jun, 2024
(a month from now) |
Ingredients: BRENTUXIMAB